Dolby Laboratories, Inc. (NYSE:DLB) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Second Quarter Fiscal Year 2025 Results.
Dolby Laboratories Inc. (DLB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 1,143,978 | $90,946,285 | +64% | 0.09% |
| 2. | Squarepoint Ops LLC Maxime Fortin (Cio) | 263,958 | $21,198,467 | +38% | 0.03% |
| 3. | Balyasny Asset Management Dmitry Balyasny | 212,323 | $17,051,660 | -54% | 0.03% |
| 4. | GLG Partners Noam Gottesman | 162,087 | $13,017,207 | +9% | 0.03% |
| 5. | Citadel Investment Group Ken Griffin | 119,007 | $9,557,452 | -65% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.15 | 3 | $200.00 | 3 | 2024-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.57 | 179 | $13,706.03 | 114,725 | 2025-06-10 | Filing | |
| $76.22 | 33,504 | $2,553,775.39 | 114,904 | 2025-06-10 | Filing | |
| $75.02 | 15,000 | $1,125,286.50 | 62,397 | 2025-06-04 | Filing | |
| $74.97 | 350 | $26,239.50 | 62,397 | 2025-05-30 | Filing | |
| $75.04 | 675 | $50,652.00 | 121,151 | 2025-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,535,722 | $605,193,833 | 0.01% | |
| 2. | 7,128,786 | $572,513,098 | 0.04% | |
| 3. | 6,033,009 | $484,510,946 | 0.01% | |
| 4. | 5,709,193 | $458,505,353 | 0.09% | |
| 5. | 2,080,987 | $167,124,066 | 0.01% |
News See All
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing First Quarter Fiscal Year 2025 results.
14 Best 52-Week High Stocks To Buy According to Analysts
After two years of substantial gains to record highs, exhaustion in the US equity markets is slowly kicking in.
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal Fourth Quarter Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal Third Quarter Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2024 Earnings Call Transcript
Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.27, expectations were $1.17. Dolby Laboratories, Inc.
Dolby Laboratories, Inc. (NYSE:DLB) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal First Quarter Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Dolby Laboratories Conference Call discussing Fiscal Fourth Quarter Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories' Conference Call discussing Fiscal Third Quarter Results.
Dolby Laboratories, Inc. (NYSE:DLB) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories’ Conference Call discussing fiscal second quarter results.